Zheng Quan Ri Bao Wang·2025-11-25 10:42Core Insights - Demand for flu-related medications, testing, and online consultations is significantly increasing, particularly in Northeast, North China, and Northwest regions, with Southern cities like Southwest and South China also experiencing rapid growth [1][2] - Orders for antiviral medications have surged, with a more than 100% month-on-month increase for Mabalaoshuwei tablets and over 85% for Oseltamivir granules since November [1] - The sales of flu testing kits have seen a month-on-month increase of over 900%, indicating a strong public demand for precise diagnosis [1] Group 1: Medication Demand - The order volume for flu-specific medications has more than doubled since November, with Mabalaoshuwei tablets increasing by over 110% and Oseltamivir granules by over 85% [1] - The coverage rate for Oseltamivir is stable at over 98%, while Mabalaoshuwei maintains around 80%, which is double compared to the same period last year [1] Group 2: Testing Services - The platform offers diverse testing services, including respiratory virus antigen and nucleic acid tests, with nearly 90% coverage for flu testing kits [2] - Home testing services have expanded from 7 to 13 cities, with capacity in 8 key cities increasing nearly twofold during the flu season [2] Group 3: Public Awareness and Education - There is a noticeable increase in public awareness regarding flu prevention, although some users still have misconceptions about medication, particularly among parents [2] - The company has launched an anti-flu service area and collaborated with top hospitals for online educational sessions to help the public respond scientifically [2] Group 4: Price Stability and Supply Chain - To address concerns about rising medication prices, the company ensures price stability through its self-operated pharmacy, "Meituan Self-operated Pharmacy" [2] - The company has initiated a direct air freight service for flu medications, ensuring next-day delivery to over 300 cities nationwide [2]